- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Gordon K. Norman, MD, executive vice president, science and innovation, Alere Medical Inc.
Gordon K. Norman, MD, is helping shape the dialogue surrounding the merging of DM with the medical home concept.
Gordon K. Norman, MD, MBA
Executive Vice President, Science and Innovation
Alere
Irvine, Calif.
He is reaching out to physicians and other clinicians to combine the medical home model with electronic health records to integrate the total health experience. Dr. Norman recognizes that adopting the medical home environment is not an easy feat for small medical groups, which will need to develop technology, special skills, capital and scalable approaches to be successful–something that is difficult to do alone. "By closely collaborating, DM and the medical home can be better than either working in isolation," he says.
Prior to joining Alere in 2005, Dr. Norman worked for PacifiCare Health Plans, where he served as regional medical director, plan medical director and vice president of healthcare quality and of DM for 11 years.
He earned his undergraduate, medical and MBA degrees from Stanford University and also was named one of Managed Healthcare Executive's Leaders in Disease Management in 2004.
Why Patient Registries Need to Make the Move From Tactical to Strategic Research Initiatives
September 6th 2022The one-sided, research-oriented approach has to change so patients have ready access to dashboards with their disease histories and pre-visit documents tailored to the patient questions.
Read More
Study: Patients with High Deductible Plans More Likely to Delay Care
September 7th 2021Patients faced with high out-of-pocket costs sometimes delay seeking care for appendicitis or diverticulitis, which can result in higher overall costs, increased risk of mortality, and a worse quality of life.
Read More
